News & Press Releases

Law360 Healthcare Authority featured insights from Member Theresa Carnegie in an article focused on the Consolidated Appropriations Act of 2026 which introduces new regulations for pharmacy benefit managers, particularly aimed at fee and cost transparency.

Competition Policy International featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.

Mintz has further enhanced its high-powered litigation practice with a five-partner team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan. 

Reuters featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.

The American Lawyer featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan. The article highlights the team’s focus on high-stakes disputes, including representing major corporations in antitrust opt-out cases, and explains why Mintz was the right fit.

Member Joanne Hawana was quoted in a Reuters article about the FDA’s plans to restrict GLP-1 ingredients in non-approved compound drugs. The article reports on the agency’s potential enforcement actions involving Hims & Hers and broader regulatory scrutiny of compounded weight-loss medications.